1-9 of 9
Hui Luo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNA Transcription

Available to Purchase
Lin Gao, Jingyi Huang, Jinquan Xia, Pan Zhao, Shaowei Dong, Wei Jiang, Qianqian Zhou, Zhenglei Xu, Hui Luo, Wenbin Zhou, Jichao Sun, Guangsuo Wang, Qingshan Geng, Jigang Wang, Chang Zou
Journal: Cancer Research
Cancer Res (2025) 85 (6): 1097–1112.
https://doi.org/10.1158/0008-5472.CAN-24-1271
Published: 14 March 2025
View articletitled, SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNA Transcription
Open the PDF for SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNA Transcription in another window
Includes: Supplementary data
Journal Articles

Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma

Available to Purchase
Liting Zhou, Jie Tian, Keke Wang, Yijie Ma, Xiaojie Chen, Hui Luo, Bingbing Lu, Nan Wang, Penglei Wang, Xuejiao Liu, Ran Zhao, Simin Zhao, Jiutao Wang, Wenna Nie, Hong Ge, Wenting Liu, Tingxuan Gu, Kangdong Liu, Mee-Hyun Lee, Xiang Li, Zigang Dong
Journal: Cancer Research
Cancer Res (2024) 84 (22): 3894–3908.
https://doi.org/10.1158/0008-5472.CAN-23-2241
Published: 15 November 2024
View articletitled, Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
Open the PDF for Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract CT246: Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancer

Free
Ziming Li, Xiaomin Dang, Dingzhi Huang, Shi Jin, Weiwei Li, Jianhua Shi, Xicheng Wang, Yiping Zhang, Zhengbo Song, Junping Zhang, Wu Zhuang, Xuewen Liu, Liyan Jiang, Xiangjiao Meng, Mingfang Zhao, Jianying Zhou, Liangming Zhang, Pingli Wang, Hui Luo, Junquan Yang, Shundong Cang, Xiang Wang, Jing Wang, Jiuwei Cui, Yan Yu, Zhihong Zhang, Junguo Lu, Weihua Yang, Gaofeng Li, Jifeng Feng, Dongqing Lv, Lin Wu, Yong Fang, Yan Wang, Yanqiu Zhao, Baoshan Cao, Wei Zhu, Zhixiang Zhuang, Qingshan Li, Mingxi Wang, Huan Zhou, Xiaorong Dong, Sheng Hu, Jian Fang, Yihong Zhang, Wenjia Wang, Ziyong Xiang, Zhe Shi, Ling Zhang, Shun Lu
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT246.
https://doi.org/10.1158/1538-7445.AM2024-CT246
Published: 05 April 2024
View articletitled, Abstract CT246: Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancer
Journal Articles

Abstract 6412: Combination of liquid biopsy and PET/CT enhances prediction of pathological response to neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma

Free
Weixiong Yang, Zengli Fang, Xiaoyan Wang, Hui Luo, Shuishen Zhang, Bo Zeng, Zhenguo Liu, Chenxuan Wang, Qiuxiang Ou, Lingling Yang, Haimeng Tang, Sai-Ching J. Yeung, Chao Cheng
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6412.
https://doi.org/10.1158/1538-7445.AM2024-6412
Published: 22 March 2024
View articletitled, Abstract 6412: Combination of liquid biopsy and PET/CT enhances prediction of pathological response to neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma
Journal Articles

Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells

Open Access
Li Xia, Jie-Yang Liu, Meng-Ying Yang, Xue-Hong Zhang, Yue Jiang, Qian-Qian Yin, Chen-Hui Luo, Hong-Chen Liu, Zhi-Jie Kang, Cheng-Tao Zhang, Bei-Bei Gao, Ai-Wu Zhou, Hai-Yan Cai, Edmund K. Waller, Jin-Song Yan, Ying Lu
Journal: Cancer Research
Cancer Res (2024) 84 (3): 479–492.
https://doi.org/10.1158/0008-5472.CAN-23-1632
Published: 01 February 2024
View articletitled, Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells
Open the PDF for Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells in another window
Includes: Supplementary data
Journal Articles

Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial

Free
Ying Cheng, Jie Wang, Caicun Zhou, Wenxiu Yao, Qiming Wang, Xuhong Min, Gongyan Chen, Xingxiang Xu, Xingya Li, Fei Xu, Yong Fang, Runxiang Yang, Guohua Yu, Youling Gong, Jun Zhao, Yun Fan, Quan Liu, Lejie Cao, Yu Yao, Yunpeng Liu, Xiaoling Li, Jingxun Wu, Zhiyong He, Kaihua Lu, Liyan Jiang, Huiqing Yu, Chengping Hu, Wenhua Zhao, Jian Zhao, Gang Wu, Dingzhi Huang, Chengshui Chen, Cuimin Ding, Baihong Zhang, Xiuwen Wang, Hui Luo, Baolan Li, Ben Zhang, Haowen Li, Ke Ma
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT038.
https://doi.org/10.1158/1538-7445.AM2022-CT038
Published: 15 June 2022
View articletitled, Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial
Journal Articles

Abstract 4753: Ovarian cancer stem cell marker ALDH1A2 is a candidate biomarker for patient selection for intraperitoneal chemotherapy

Free
Brandon-Luke L. Seagle, Monica Dandapani, Chen Hui Luo, Claire Hoppenot, Robert Samuelson, Kevin H. Eng, Kunle Odunsi, Shohreh Shahabi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4753.
https://doi.org/10.1158/1538-7445.AM2016-4753
Published: 15 July 2016
View articletitled, Abstract 4753: Ovarian cancer stem cell marker ALDH1A2 is a candidate biomarker for patient selection for intraperitoneal chemotherapy
Journal Articles

Abstract 4754: Overexpression of TSH and ERBB2 (HER2) receptors is associated with sharply decreased survival in high grade serous ovarian cancer

Free
Brandon-Luke L. Seagle, Monica Dandapani, Chen Hui Luo, Claire Hoppenot, Robert Samuelson, Kevin H. Eng, Kunle Odunsi, Shohreh Shahabi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4754.
https://doi.org/10.1158/1538-7445.AM2016-4754
Published: 15 July 2016
View articletitled, Abstract 4754: Overexpression of TSH and ERBB2 (HER2) receptors is associated with sharply decreased survival in high grade serous ovarian cancer
Journal Articles

The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling

Free
Chenghao Peng, Zhengxin Chen, Shuai Wang, Hong-Wei Wang, Wenjin Qiu, Lin Zhao, Ran Xu, Hui Luo, Yuanyuan Chen, Dan Chen, Yongping You, Ning Liu, Huibo Wang
Journal: Cancer Research
Cancer Res (2016) 76 (8): 2340–2353.
https://doi.org/10.1158/0008-5472.CAN-15-1884
Published: 14 April 2016
View articletitled, The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling
Open the PDF for The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling in another window
Includes: Supplementary data